reported that NRG1 fusions were identified in 0.36% lung adenocarcinoma patients (six of 1,681), and except for invasive mucinous adenocarcinoma, those fusions were also found in other subtypes, including solid, acinar and lepidic (39). This evidence concerns the gene NRG1 and lung adenocarcinoma.